2019 Refresher-Radiation and Immune Therapy

This session will help radiation oncology professionals remain current in the field of immunotherapies and radiation combined with immunotherapies. Attendees need to be able to recognize and identify side effect profiles and presenting symptoms of toxicities from immunotherapies which are used clinically. Novel tumor vaccines that use conventional and exploratory cancer therapies will be discussed. 

Target Audience

The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, radiation physicists, nurses, radiation therapists, and radiation dosimetrists.

Learning Objectives

  • Describe the mechanisms and potential utility of radiation-mediated in situ vaccines.
  • Discuss the importance of clinical trials in studying immune-oncology therapies and how such trials might be designed.
Course summary
Available credit: 
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
  • 1.00 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

Course opens: 
03/20/2019
Course expires: 
04/12/2019
Cost:
$0.00
Rating: 
0

Chandon Guha, MD is employed by Albert Einstein College of Medicine, Montefiore Medical Center, receives compensation/remuneration/funding from Celldex Therapeutics, Focused Ultrasound Foundation, Johnson and Johnson, National Institute of Health, Varian, holds ownership or investment interests in Rubicon Therapeutics, and holds a  leadership position at NRG/RTOG.

The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.

Disclosure link: 
Committee Disclosures

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

Available Credit

  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
  • 1.00 SA-CME

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

    The American Society for Radiation Oncology (ASTRO) designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.

Price

Cost:
$0.00
Please login or register to take this course.

Policies: 

  • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
  • No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
  • ASTRO staff cannot make modifications to your submitted materials.
     

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.